Clinical Trial Update: Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer [Phase 3]

View source ↗

Summary

This document provides a Phase 3 clinical trial update for premenopausal patients with hormone-responsive, HER2-negative, lymph node-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Asan Medical Center | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN